Boston, MA, United States of America

Cheng-kui Pei

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng-kui Pei. Retrieved from https://idiyas.com/inventor/cheng-kui-pei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cheng-kui Pei: Innovator in Cancer Research

Introduction

Cheng-kui Pei is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer research. He is recognized for his innovative work in developing compounds that target specific proteins involved in disease processes.

Latest Patents

Cheng-kui Pei holds a patent for "Inhibitors of TRIM33 and methods of use." This patent relates to a compound that modulates the activity of TRIM33, which plays a crucial role in various diseases. The pharmaceutical composition derived from this compound offers potential methods for treating or preventing diseases associated with TRIM33.

Career Highlights

Pei is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts research aimed at advancing cancer treatment. His work focuses on understanding the molecular mechanisms of cancer and developing targeted therapies.

Collaborations

One of his notable collaborators is Jun Qi, with whom he has worked on various research projects aimed at enhancing cancer treatment strategies.

Conclusion

Cheng-kui Pei's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving therapeutic options for patients. His work continues to pave the way for advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…